FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011430715> ?p ?o ?g. }

• W2011430715 endingPage "828" @default.
• W2011430715 startingPage "825" @default.
• W2011430715 abstract "Malignant neoplasia represents the second cause of disease-related mortality and, among all patients diagnosed with cancer, 70% will receive chemotherapy during the course of treatment. As a consequence, an increasing number of researchers have focused their attention on the search for more specific anticancer therapies associated with fewer side effects. Leukopenia is an important adverse effect associated with chemotherapy. Secondary infection is very common among leukopenic patients, directly affecting the continuity of the chemotherapeutic treatment and leading to possible complications in tumor immune defense. Atorvastatin, a type of statin, is a known agent used to control hypercholesterolemia. Trans-caryophyllene, isolated from a resinous oil extracted from the copaiba tree, possesses anti-inflammatory and analgesic properties. The AIM of the present study was to evaluate, through a complete leukocyte count, the systemic immunomodulation potential of pentoxifylline (PTX), atorvastatin and trans-caryophyllene, as well as the possible prophylactic role of these drugs against secondary leukopenia, in an experimental chemotherapy model induced by 5-fluorouracil (5-FU) in wistar rats. A total of 32 male wistar rats were used, 24 of which were submitted to treatment with atorvastatin, PTX and trans-caryophyllene prior to the administration of chemotherapy. The Shapiro-Wilk test was used to verify normality and the Kruskal-Wallis test was used for negative data in the normality test. Among the drugs selected, atorvastatin exhibited the best preventive potential in regards to leukopenia secondary to experimental chemotherapy induced by 5-FU, in comparison to the group receiving saline solution, while PTX amplified such alterations in the leukograms of the animals in this trial." @default.
• W2011430715 created "2016-06-24" @default.
• W2011430715 creator A5009915446 @default.
• W2011430715 creator A5017940299 @default.
• W2011430715 creator A5046492996 @default.
• W2011430715 creator A5060935473 @default.
• W2011430715 creator A5090720523 @default.
• W2011430715 date "2015-04-09" @default.
• W2011430715 modified "2023-10-16" @default.
• W2011430715 title "Atorvastatin and trans-caryophyllene for the prevention of leukopenia in an experimental chemotherapy model in Wistar rats" @default.
• W2011430715 cites W11272935 @default.
• W2011430715 cites W1511187821 @default.
• W2011430715 cites W1517473500 @default.
• W2011430715 cites W1742102714 @default.
• W2011430715 cites W1823197934 @default.
• W2011430715 cites W1942097125 @default.
• W2011430715 cites W1967363201 @default.
• W2011430715 cites W1969144125 @default.
• W2011430715 cites W1976971060 @default.
• W2011430715 cites W1977589318 @default.
• W2011430715 cites W1983737046 @default.
• W2011430715 cites W1987108013 @default.
• W2011430715 cites W2000915744 @default.
• W2011430715 cites W2015385658 @default.
• W2011430715 cites W2018400241 @default.
• W2011430715 cites W2022924383 @default.
• W2011430715 cites W2024788721 @default.
• W2011430715 cites W2026209276 @default.
• W2011430715 cites W2033831171 @default.
• W2011430715 cites W2035059839 @default.
• W2011430715 cites W2061446775 @default.
• W2011430715 cites W2064755838 @default.
• W2011430715 cites W2066015272 @default.
• W2011430715 cites W2067153228 @default.
• W2011430715 cites W206821728 @default.
• W2011430715 cites W2071080761 @default.
• W2011430715 cites W2076046120 @default.
• W2011430715 cites W2083738828 @default.
• W2011430715 cites W2084147384 @default.
• W2011430715 cites W2112583269 @default.
• W2011430715 cites W2127549376 @default.
• W2011430715 cites W2137399557 @default.
• W2011430715 cites W2150095869 @default.
• W2011430715 cites W2162720454 @default.
• W2011430715 cites W2167399895 @default.
• W2011430715 cites W2334814489 @default.
• W2011430715 cites W384745426 @default.
• W2011430715 cites W4243605665 @default.
• W2011430715 cites W4313341439 @default.
• W2011430715 cites W94750915 @default.
• W2011430715 doi "https://doi.org/10.3892/mco.2015.544" @default.
• W2011430715 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4487044" @default.
• W2011430715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26171189" @default.
• W2011430715 hasPublicationYear "2015" @default.
• W2011430715 type Work @default.
• W2011430715 sameAs 2011430715 @default.
• W2011430715 citedByCount "17" @default.
• W2011430715 countsByYear W20114307152016 @default.
• W2011430715 countsByYear W20114307152017 @default.
• W2011430715 countsByYear W20114307152018 @default.
• W2011430715 countsByYear W20114307152019 @default.
• W2011430715 countsByYear W20114307152020 @default.
• W2011430715 countsByYear W20114307152021 @default.
• W2011430715 countsByYear W20114307152022 @default.
• W2011430715 crossrefType "journal-article" @default.
• W2011430715 hasAuthorship W2011430715A5009915446 @default.
• W2011430715 hasAuthorship W2011430715A5017940299 @default.
• W2011430715 hasAuthorship W2011430715A5046492996 @default.
• W2011430715 hasAuthorship W2011430715A5060935473 @default.
• W2011430715 hasAuthorship W2011430715A5090720523 @default.
• W2011430715 hasBestOaLocation W20114307151 @default.
• W2011430715 hasConcept C121608353 @default.
• W2011430715 hasConcept C126322002 @default.
• W2011430715 hasConcept C143998085 @default.
• W2011430715 hasConcept C197934379 @default.
• W2011430715 hasConcept C203014093 @default.
• W2011430715 hasConcept C2776694085 @default.
• W2011430715 hasConcept C2777482532 @default.
• W2011430715 hasConcept C2780873365 @default.
• W2011430715 hasConcept C71924100 @default.
• W2011430715 hasConcept C90924648 @default.
• W2011430715 hasConcept C98274493 @default.
• W2011430715 hasConceptScore W2011430715C121608353 @default.
• W2011430715 hasConceptScore W2011430715C126322002 @default.
• W2011430715 hasConceptScore W2011430715C143998085 @default.
• W2011430715 hasConceptScore W2011430715C197934379 @default.
• W2011430715 hasConceptScore W2011430715C203014093 @default.
• W2011430715 hasConceptScore W2011430715C2776694085 @default.
• W2011430715 hasConceptScore W2011430715C2777482532 @default.
• W2011430715 hasConceptScore W2011430715C2780873365 @default.
• W2011430715 hasConceptScore W2011430715C71924100 @default.
• W2011430715 hasConceptScore W2011430715C90924648 @default.
• W2011430715 hasConceptScore W2011430715C98274493 @default.
• W2011430715 hasIssue "4" @default.
• W2011430715 hasLocation W20114307151 @default.
• W2011430715 hasLocation W20114307152 @default.
• W2011430715 hasLocation W20114307153 @default.
• W2011430715 hasLocation W20114307154 @default.

• next